Immunopath Doc - Nichols Flashcards
- Definitions of Hypersensitivity I, II, III, IV - Know most common serological tests in rheumatology and their respective diseases - Know most common therapeutic agents for immunopathologic diseases and the MOA (mechanism of action). - Know systemic approach for Systemic Lupus Erythematosus, Sjogren Syndrome, systemic Sclerosis - Understand difficulty of dx and tx transplant rejection - know features of graft vs. host disease - Know features of common congenital immunodef. diseases - Kn
A rapid immunological reaction within minutes after presentation of antigen bound to mast cells is what type of hypersensitivity?
Type 1
What are the clinical features /characteristics of anaphylaxis?
Shock, edema, bronchoconstriction
Type 2 hypersensitivity is what?
IIa: Antibody-dependent
Complement-mediated
Cytotoxicity or
IIb: Antibody-dependent
Cell-mediated
Cytotoxicity
Immune complex-mediated hypersensitivity is what type?
- where is it most damaging?
Type 3
- Blood vessels and glomeruli
Cell-mediated hypersensitivity is an immunological reaction caused by
sensitized CD-4 T cells, sometime triggering macrophages response.
Anti-cyclic citrullinated peptide (anti-CCP)
R.Arthritis
Anti-centromere
CREST syndrome
Anti-Jo-1 (one type of anti synthetase)
Polymyositis / dermatomyositis
Anti-Scl70 (anti-DNA topoisomerase)
Systemic sclerosis, diffuse
Anti-RNA polymerase (anti-U3 RNP)
systemic sclerosis
Anti-U1 RNP (anti-RNP)
mixed connective tissue diseases
Anti-Smith (anti-Sm)
Lupus
Anti-dsDNA
Lupus
Anti-nuclear (ANA)
Lupus and other rheumatic diseases
Anti-SSA (anti-Ro)
Sjogren syndrome, neonatal lupus, subQ lupus
Anti-SSB (anti-La)
Sjogren syndrome, neonatal lupus, subQ lupus
Anti-MPO (myeloperoxidase)
microscopic polyangiitis, eosinophilic granulomatosis w/ polyangiitis (Churg Strauss)
Anti-proteinase3
granulomatosis w/ polyangiitis
What are some immunosuppressive drugs that are used for treating cancer that could be used as immunosuppressive therapy?
- methotrexate
- cyclophosphamide
What are the names of 2 drugs that Nichols mentioned in his word doc that are given to transplant patients to prevent or treat transplant rejections?
- What are their MAO?
Cyclosporine
- tacrolimus
- calcineurin inhibitors
What does calcineurin do?
- phosphatase, remove phosphate from the nuclear reg. protein in lymphocytes.
- thus promoting translocation of protein to nucleus to act as TF for lymphocyte activation, TNF, INF-G, IL-2, IL-4.
About how much of calcineurin activity does Cyclosporine and Tacroliumus block at therapeutic level?
about half of the activity
What is needed for F/U when prescribing Cyclosporin and Tacroliumus?
- regular blood testing
What does mycophenolate mofetil do?
- what is it MOA?
- what is it used for?
- inhibits lymphocyte proliferation
- reversible inhibitor of INP DH in purine (guanine) synthesis
- tx autoimmune diseases, particular Lupus and preventing transplant rejection
What is azathioprine?
purine analogue
- tx Lupus, R.A, and other autoimmune disases
What is hydroxycholorquine?
- anti-malarial antibiotic w/ anti-inflammatory activities.
- tx. Lupus, R.A
- low toxicity
Define Systemic Lupus Erythematosus
- prototype multisystem autoimmune disease
SLE: epidemiology
Common, 13X more in women, 1/245 black women
SLE: pathogenesis
Failure of self-tolerance
SLE Gross Pathology:
non-erosive synovitis (inflammation of the synovial membrane) in 90%,
46% pleuritis
25% pericarditis
peritonitis
(basically, all fluid-filled cavities)
- Libman-Sacks endocarditis: nonbacterial endocarditis formed by vegetation.
SLE micro path:
acute necrotizing vasculitis of small arteries and arterioles (fibrinoid deposit)
- nephritis in 50%
- cerebritis in 50%
SLE symptoms:
- joint pain
- fever
- fatigue
- weight loss
- pleuritic chest pain
- photosensitivity
- nephrotic syndrome
- angina
- alopecia
- myalgias
SLE signs:
- skin rash over bridge of nose and check
- edema: 1st in feet
- hematuria
- neuropsychiatric
- oral ulcers
- interarticular skin rashes
- peri-ungual erythema around fingernails
- alopecia
SLE dx:
ANA, present in 100%
also present in 15% of normal people
SLE tx:
corticosternoids
immunosuppressive meds
SLE prognosis:
90% 5 yr survival
80% 10 yr ‘’’’
Define Sjogren Syndrome
autoimmune chronic inflammatory diseases of lacrimal glands and salivary glands, causing dry eyes and dry mouth.
- eye: kerato-conjunctivitis sicca
- oral: xerostomia
primary form: limited to eye and mouth –> sicca snydrome
secondary form: associated with autoimmune disorders like R.A, lupus.
Sjogren Syndrome Epidemiology:
90% 35-45 y/o women
secondary form more common than primary form
Sjogren Syndrome: pathogenesis
T cell mediated immunological attack of self-Ag in ductal epithelial cells.
- or viral infection that has tropism in cells of these glands
Sjogren Syndrome Gross Patho:
dry ocular and dry mouth
- enlarged salivary and lacrimal glands
Sjogren Syndrome Micro Path:
1) infiltration of CD4 T cells
2) destruction of gland architecture
+/- plasma cells,
+/- germinal centers
Renal: interstitial nephritis rather than glomerulonephritis
Sjogren Syndrome Symptoms:
dry eyes, dry mouth
Sjogren Syndrome Signs:
dry mucous membrane of eyes and mouth
- conjunctival ulcers
- oral ulcers
- enlarged salivary and lacrimal glands
Sjogren Syndrome Dx:
Anti-SSA, SSB.
Sjogren Syndrome Tx:
topical therapy
- systemic cholinergic agents
- hydroxychloroquine
Sjogren Syndrome prognosis:
notorious for developing lymphoma
Systemic Sclerosis definition:
chronic disease characterized by abnormal accumulation of fibrous tissue in skin and other organs
Diffuse: widespread skin, early visceral
limited: skin of fingers, forearms, face, late visceral involvement
within context of CREST syndrome
Systemic Sclerosis epidemiology:
10-20 M / year
F:M - 3:1
50-60 y/o
most severe: black women
Systemic Sclerosis Pathogenesis
abnormal immune response and vascular damage leads to increase growth factors and fibrosis.
CD4 T cells stimulate fibroblast to produce collagen
Microvascular disease: intimal proliferation, capillary dilation, endothelial injury (increase vWF) + platelet activation –> fibrosis
Systemic Sclerosis gross path:
skin
- areas initially edematous, ultimately fibrotic
- begin in face and fingers
- decrease motility leads to masklike face and clawlike hands
GI involvement 90%
Systemic Sclerosis micro path:
dense collagen deposition in dermis
- thinning of epidermis
- thickening of capillary/ arterial basal lamina
- vascular changes promote HTN and renal failure, in lung - pulmonary HTN and interstitial fibrosis.
Systemic Sclerosis symptoms:
Raynaud’s phenomenon
- numbness/tingling/ cyanosis of peripheral skin
- jt pain
Systemic Sclerosis sign:
edema of hands and feet, most prominent in the morning
later: thickened, hard / shiny skin – long bones/ lower legs
Systemic Sclerosis Dx:
generalized cutaneous sclerosis, HTN, renal failure, pulmonary HTN and fibrosis.
Systemic Sclerosis Tx:
Exercise, splinting, avoid cold
Pharm: antifibrotic
Hemotopoietic stem cell transplantion
Systemic Sclerosis Prognosis:
Age, gender adjusted mortality rate increase 5-8 times.
Hyperacute Transplant Rejection:
Hypersensitivity Type 2
- vascular injury after attachment (kidney, heart)
- ABO blood type
- cytotoxic Ab against donor organs
-
Acute Rejection
w/in 3 months
Cell mediated (most important): donor macrophage and host T cells
Antibody mediated:
type 2 necrotizing vasculitis with vessel damage and thrombosis
Tx: Cyclosporin A
GVH:
Donor lymphocytes produce IL-2, which activates NK cells (effectors of GVH injury)
-